Our label-free technologies

As our label-free technologies perform drug-target MoA under physiological conditions and in human samples, the test compound preserves its original structure and the exact same molecular structure that would be used in therapy.

We provide unbiased information about your drug and its natural environment that helps you find:

  • The extreme limits of the physiological process
  • How the physiological process can be modulated
  • Why the individual is responding to this compound at the molecular level
  • A description of the pathophysiology of the disease

Preclinical stage

Identify the mode of action of your compound with our NPOT® technology

Read more

From preclinical to clinical stage

Adopt a robust solution that can ensure the success of your Phase II study and accompany you in achieving the success of your drug candidate in Phase III

Read more

Clinical stage

Identify a cohort of patients responding to your therapy with our PIMS® technology

Read more